64-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets

Stopped The study was not started due to the sponsor choosing to not fund the trial.

Conditions

• Brain Metastases
• Documented Her2 Overexpression
• Advanced Solid Tumor
• Neurologically Stable

Interventions

• DRUG: MM-302
• DRUG: Trastuzumab

Sponsor

Pamela Munster